ENFUMOSA: inflammatory mediators and human bronchial responses (1998)
Archive record. Copy preserved by the Internet Archive on 4 May 1998.
Original title: ENFUMOSA : M. Molimard Influence of lipopolysaccharide (LPS) and interleukin 1-ß (IL1-ß) on human isolated bronchi responsiveness to bradykinin, substance-P and neurokinin A.
This historical document is not current medical guidance. Read the original copy
Key points
- Abstract of a laboratory pharmacology talk on isolated human bronchi, presented on 14 February 1998.
- Authors: Mathieu Molimard (Bordeaux) and Charles Advenier (Paris).
- Part of the smooth muscle session of ENFUMOSA, a European severe asthma network.
- Captured on 4 May 1998; page last updated 30 January 1998.
What this page was
ENFUMOSA (European Network For Understanding Mechanisms of Severe Asthma) was a research network belonging to the European Commission's BIOMED 2 program. The page said its fourth quarterly meeting took place on 13 and 14 February 1998 in Montpellier, with support from INSERM and an industry sponsor named on the page. This page held the abstract of a talk by Mathieu Molimard and Charles Advenier, from pharmacology departments in Bordeaux and Paris, on a morning "smooth muscle" session of Saturday 14 February 1998 (08:00 to 09:00). It was last updated on 30 January 1998 and captured by the web archive on 4 May 1998.
What it covered
The work was done on pieces of human bronchus kept in the laboratory. The authors asked whether bacterial endotoxin or the inflammatory messenger interleukin-1 beta could make the airway muscle react more strongly to three signaling molecules (bradykinin, substance P and neurokinin A). The page reported that pretreatment increased the contractile response over time and then examined, with a series of blocking agents, which pathways seemed involved, notably products of the cyclooxygenase pathway and a bradykinin receptor type. It introduced the topic by noting that airway muscle cells are not only contractile but can take part in inflammation.
What has changed
This is an experiment on isolated tissue, reported at a 1998 research meeting. It describes mechanisms in the laboratory, not what happens in a person with asthma, and offers no guidance on diagnosis or treatment. Questions about your own health belong with a clinician.
Related pages
AsmaNet publishes educational information that does not replace advice from a doctor or occupational health professional. If someone is struggling to breathe, call your local emergency number. This content has not been reviewed by a clinician.